Literature DB >> 9633062

Psychosocial outcome after ICD implantation: a current perspective.

S S Heller1, M A Ormont, L Lidagoster, R R Sciacca, S Steinberg.   

Abstract

Depression and reduced sexual functioning have been identified as problems following ICD placement. We examined these issues, and multiple other quality-of-life measures, and their relationship to ICD and ICD discharge. Patients were 64 +/- 11 years old, 72% male, and had undergone ICD 20 +/- 14 months previously. Fifty-eight patients responded to a confidential biopsychosocial questionnaire. Positive attitudes toward the procedure increased from 52% before to 76% after implantation. Satisfaction correlated most strongly with less anger (P = 0.002, r = 0.45), less worry about ICD size (P = 0.007, r = 0.38), less sadness (P = 0.01, r = 0.37), and perceived better health (P = 0.01, r = 0.35). Of these ICD patients, 20%-58% reported measures of depression, and sexual frequency was reduced in 45%. Despite successful ICD placement, health concern increased in 62% of the respondents. Thirty-nine percent attended support groups; 96% found them very helpful. Mean number of ICD discharges described by responders was 5 +/- 11. Fifty percent of our sample reported > or = 1 shock; equal numbers had 1, 2-5, 6-10, and more than 10 shocks. Sixty-two percent of men had at least one discharge compared to 13% of women. After controlling for cardiac clinical variables, experiencing > or = 1 ICD shock was strongly associated with anxiety about family (odds ratio = 7.3), reduced new activities (odds ratio = 6.9), increased sadness (odds ratio = 6.2), and health worry (odds ratio = 5.8). Experiencing > or = 5 ICD shocks was strongly associated with increased health concern (odds ratio = 13.6), increased sadness (odds ratio = 12.5), increased fatigue (odds ratio = 6.1), current sadness (odds ratio = 5.8), and increased nervousness (odds ratio = 5.3). ICD implantation powerfully affects quality-of-life. Postimplantation health concern is paradoxically increased despite improvement in actual health. Negative emotions are associated with defibrillator discharge.

Entities:  

Mesh:

Year:  1998        PMID: 9633062     DOI: 10.1111/j.1540-8159.1998.tb00179.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  15 in total

1.  Audit of implantable cardioverter-defibrillators in a single UK centre.

Authors:  S Gupta; H Hasan; O Valencia; S Jones; E Rowland; A J Camm; C W Pumphrey; D E Ward
Journal:  BMJ       Date:  1999-05-22

2.  Acute Effects of Implantable Cardioverter-Defibrillator Shocks on Biomarkers of Myocardial Injury, Apoptosis, Heart Failure, and Systemic Inflammation.

Authors:  Jordan Brewster; Travis Sexton; Gary Dhaliwal; Richard Charnigo; Gustavo Morales; Kevin Parrott; Yousef Darrat; John Gurley; Susan Smyth; Claude S Elayi
Journal:  Pacing Clin Electrophysiol       Date:  2017-03-08       Impact factor: 1.976

3.  How different from pacemaker patients are recipients of implantable cardioverter-defibrillators with respect to psychosocial adaptation, affective disorders, and quality of life?

Authors:  F Duru; S Büchi; R Klaghofer; H Mattmann; T Sensky; C Buddeberg; R Candinas
Journal:  Heart       Date:  2001-04       Impact factor: 5.994

4.  The impact of an implantable cardioverter defibrillator: the Leiden follow-up study of ICD patients and their partners.

Authors:  N M S de Groot; M Bootsma; E E van der Wall; M J Schalij
Journal:  Neth Heart J       Date:  2003-04       Impact factor: 2.380

5.  Views of patients with heart failure about their role in the decision to start implantable cardioverter defibrillator treatment: prescription rather than participation.

Authors:  Anders Agård; Rurik Löfmark; Nils Edvardsson; Inger Ekman
Journal:  J Med Ethics       Date:  2007-09       Impact factor: 2.903

6.  Impact of implantable cardioverter-defibrillator recalls on patients' anxiety, depression, and quality of life.

Authors:  Manish Undavia; Nathan E Goldstein; Pilar Cohen; Kamoltip Sinthawanarong; Magdalena Singson; Divaya Bhutani; Tracey Munson; Joseph Anthony Gomes; Avi Fischer; Davendra Mehta
Journal:  Pacing Clin Electrophysiol       Date:  2008-11       Impact factor: 1.976

Review 7.  Ventricular Tachycardia with ICD Shocks: When to Medicate and When to Ablate.

Authors:  Amir AbdelWahab; John Sapp
Journal:  Curr Cardiol Rep       Date:  2017-09-13       Impact factor: 2.931

Review 8.  Surgical therapy of ventricular arrhythmias.

Authors:  T Doenst; G Faerber; S Grandinac; T Kuntze; L Menicanti; M A Borger; F W Mohr
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2007-06

9.  Comprehensive cardiac rehabilitation programme for implantable cardioverter-defibrillator patients: a randomised controlled trial.

Authors:  A Fitchet; P J Doherty; C Bundy; W Bell; A P Fitzpatrick; C J Garratt
Journal:  Heart       Date:  2003-02       Impact factor: 5.994

10.  Implementation of guidelines for implantable cardioverter-defibrillator therapy in clinical practice: Which patients do benefit?

Authors:  S C Wijers; B Y M van der Kolk; A E Tuinenburg; P A F Doevendans; M A Vos; M Meine
Journal:  Neth Heart J       Date:  2013-06       Impact factor: 2.380

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.